Orthopedic Bone Cement and Casting Materials Market: By Product Type (Bone Cement, Casting Material (Fiberglass, Plaster, and Others), By Application (Trauma Cases, Joint Arthroplasty, Spine Injuries, Spine Injuries, Others), By End User (Orthopaedic Clinics, Hospitals, Ambulatory Surgical Centres) and Geography  

Orthopedic Bone Cement and Casting Materials Market size was valued at USD 2.8 billion in 2022 and is poised to grow at a CAGR of 7.9% from 2023-2029. Polymethyl methacrylate (PMMA), is a commonly used bone cement and is widely used to implant fixation in various orthopedic trauma surgery. Furthermore, other commercially available bone cements include calcium phosphate cement (CPC), Glass polyalkenoate cement (GPCs), and others Bone cement fills the gaps between the bone and implant and holds the implant against the bone. Bone cement has no adhesive property but they rely on the interlocking mechanism between the prosthesis and the irregular bone surface. CPCs have low mechanical strength so they are minimally used in cranial and maxilla-facial surgeries strength.  The Orthopedic Bone Cement and Casting Materials Market is consolidated due to the presence of many market players competing with new product launches overcoming the drawbacks of existing products and expanding the applications of bone cement and casting material. For instance, in March 2017, Medtronic Plc got U.S. Food and Drug Administration Approval for its Kyphon Xpede Bone Cement for fixation of pathological fractures of the sacra vertebral body. Furthermore, companies also focus on inorganic growth to strengthen their market position. For instance, in June 2015, DJO Global, Inc. acquired assets from Zimmer Biomet Holdings Inc. including Biomet Cobalt Bone Cement, Optivac Cement mixing Accessories, and others for the U.S. marketplace through its subsidiary, Encore Medical, L.P. Orthopedic bone cement is used to anchor artificial joints such as elbow joints, shoulder, joints, and knee joints.